US 7731971
Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptides
granted A61KA61K2039/5158A61K2039/53
Quick answer
US patent 7731971 (Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptides) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2039/5158, A61K2039/53, A61K2039/54, A61K2039/545